BTG3 and Crohn disease: The prevalence of ANA, P-ANCA, ASCA IgG, and anti-GAD and anti-TPO antibodies were slightly increased compared to healthy controls, but not at all to the same magnitude as in patients with Crohńs disease, ulcerative colitis, diabetes mellitus or thyroid disorders [7], [8], [12], [27], [28].